Genes with dual proto-oncogene and tumor suppressor gene activities are frequently altered by protein losses in colon cancers.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 26 04 2023
accepted: 29 06 2023
medline: 16 8 2023
pubmed: 11 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Cancer genes are largely categorized into tumor suppressor gene (TSG) and proto-oncogene, but many have dual activities depending on the cellular context. In the present study, we analyzed DYRK1B, ESRP1, MTSS1, ADAMTS1, and INPP5F genes known to possess the dual activities in sporadic colon cancers (CCs). By the mutation analysis, we identified DYRK1B, ESRP1, MTSS1, ADAMTS1, and INPP5F frameshift mutations in 2, 2, 3, 3, and 1 CCs in instability-high (MSI-H) cases (1.1-3.2% of MSI-H CCs), respectively, but not microsatellite stable (MSS) cases. One CC showed regional heterogeneous mutations (RHM) of ESRP1 mutation. Immunohistochemistry identified protein expression of ESRP1, MTSS1, and ADAMTS1 in the CCs, revealing that approximately 30% of CCs lost the protein expression irrespective of the MSI status. Our study showed that dual TSG and proto-oncogene genes DYRK1B, ESRP1, MTSS1, ADAMTS1, and INPP5F harbored low incidences of inactivating mutations, but that the protein losses were frequent in CCs. Our study suggests a possibility that the dual-function genes could be altered mainly at the expression level, which might contribute to CC pathogenesis.

Identifiants

pubmed: 37429176
pii: S0344-0338(23)00359-X
doi: 10.1016/j.prp.2023.154659
pii:
doi:

Substances chimiques

MTSS1 protein, human 0
Microfilament Proteins 0
Neoplasm Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154659

Informations de copyright

Copyright © 2023 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There is no conflict of interest for the authors.

Auteurs

Jae Woong Kim (JW)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea.

Ha Yoon Mo (HY)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea.

Hyun Ji Son (HJ)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea.

Nam Jin Yoo (NJ)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea.

Chang Hyeok Ann (CH)

Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea. Electronic address: achcolo@catholic.ac.kr.

Sug Hyung Lee (SH)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea. Electronic address: suhulee@catholic.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH